semaglutide essence trial PDF) 2.4 mg in Participants With Metabolic Dysfunction‐Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 essence study semaglutide Phase 3

GLP-1 agonists are a class of prescription medications that were developed to help people with type 2 diabetes manage blood sugar levels

Based on the current biopharmaceutical landscape in early 2026, Viking Therapeutics (VKTX) remains one of the most attractive bolt-on acquisition targets for large-cap pharma companies looking to secure a foothold in the $100 billion obesity market

A new non-traditional antibacterial drug fluorothiazinoneclinical research in patients with complicated urinary tract infections

As confirmed by this study, carnitine supplemented to growing yeast cultures has a protective effect against hydrogen peroxide and a detrimental effect when carnitine is combined with DTT (Franken and Bauer, 2010)